Stimwave Technologies
Pompano Beach, US · Founded 2010 · Delaware corporation · 2 known investors
Find your way into Stimwave Technologies
Sign up to see every warm intro you have to Stimwave Technologies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Stimwave Technologies team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Stimwave Technologies was founded in 2010 by Laura Tyler Perryman.
LT
Laura Tyler PerrymanFounder
RG
Regina GrovesExecutive
VS
Virginia SullivanNamed on SEC filing
ML
Marc LoevNamed on SEC filing
RC
Richard Chen MaoNamed on SEC filing
GP
Gary PerrymanNamed on SEC filing
SS
Scott SidwellNamed on SEC filing
AB
Aure BruneauNamed on SEC filing
JG
Jeffrey GoldbergNamed on SEC filing
RG
Richard GumerNamed on SEC filing
Board
PL

RK
Robert K. AndersonBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$5.3M disclosed across 2 rounds · 2014–2020
▶$3.3MraisedSep 2020 · 15 investors · BiotechnologyRule 506(b)
▶$3.3MraisedSep 2020 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul LavioletteDirector
- Virginia SullivanExecutive Officer
- Marc LoevDirector
- Richard Chen MaoDirector
- Gary PerrymanDirector
- Scott SidwellExecutive Officer
- Laura Tyler PerrymanDirector
- Aure BruneauExecutive Officer
- Jeffrey GoldbergDirector
- Richard GumerDirector
- Regina GrovesExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $3.3M
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MraisedJul 2014 · 1 investors · Other Health CareRule 506(b)
▶$2MraisedJul 2014 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Gary PerrymanDirector
- Laura T PerrymanExecutive Officer, Director
- Robert K. AndersonDirector
- Offering amount
- $6M
- Amount sold
- $2M
- Minimum investment
- $1
- First sale
- Jul 2014
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 7
Sofwave MedicalSofwave develops non-invasive medical aesthetic devices using next-generation technology for skin revitalization, muscle toning, and facial treatments. The company serves aesthetic practices and clinics seeking FDA-cleared solutions for wrinkle reduction, skin laxity, and body contouring.
Shockwave MedicalShockwave Medical develops intravascular lithotripsy (IVL) catheter systems used to treat calcified cardiovascular disease, marketed to interventional cardiologists and vascular specialists. Its products are medical devices consisting of catheters paired with generators.
Biowave CorporationBioWave develops patented high-frequency neurostimulation devices that deliver therapeutic stimulation deep into the body to block pain signals at the nerve source, aimed at chronic pain patients and athletes. Its products are used in settings such as Veterans Affairs, orthopedic and pain health systems, and by professional sports trainers.
SecondWave Systems, Inc.SecondWave Systems develops a noninvasive, wearable ultrasound stimulation device that modulates nerves, cells, and organs deep in the body for at-home treatment of conditions such as inflammation and pain. The platform is aimed at patients and physicians as an alternative to medication-based therapies for debilitating or life-threatening diseases.
StimlabsStimLabs develops regenerative medicine products, including its Corplex P device, used by physicians for wound healing and complex clinical cases. The company markets a portfolio of regenerative technologies for patient care.
Neuwave MedicalNeuWave Medical develops the NeuWave Microwave Ablation System, a device used by healthcare professionals to ablate soft tissue, including non-resectable liver tumors, in percutaneous, open surgical, and laparoscopic settings. The system includes a probe portfolio and ABLATE-IQ software for margin confirmation, and is marketed for use in the United States; the company is a wholly owned subsidiary of Quantum Surgical, Inc.
Radwave TechnologiesRadwave develops an electromagnetic tracking platform for surgical navigation and interventional procedures that provides high accuracy and resistance to electromagnetic interference. The platform is designed for clinical use in minimally invasive and interventional medical applications.
Companies working in the same space as Stimwave Technologies.
Frequently asked questions
- Who founded Stimwave Technologies?
- Stimwave Technologies was founded by Laura Tyler Perryman in 2010.
- Who are Stimwave Technologies's investors?
- Stimwave Technologies's investors include Emergent Medical Partners, LLP, SV Health Investors.
- How much funding has Stimwave Technologies raised?
- Stimwave Technologies has disclosed $5.3M raised across 2 rounds.
- Where is Stimwave Technologies headquartered?
- Stimwave Technologies is headquartered in Pompano Beach, US.




